source
- LifeMine Therapeutics secures $263 million to develop safer transplant immunosuppressantLifeMine Therapeutics announced it has raised a total of $263 million through two venture financing rounds. The capital, which includes a newly disclosed $75 million Series D round, will be used t…
- FDA approves Moderna flu vaccineThe U.S. Food and Drug Administration granted approval to Moderna's seasonal flu vaccine, adding another product to the company's portfolio. The approval was announced late Wednesday, after a repo…